- Report
- January 2022
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- November 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- November 2023
- 30 Pages
Global
From €2260EUR$2,275USD£1,879GBP
€3229EUR$3,250USD£2,685GBP
- Report
- November 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- November 2023
- 126 Pages
Global
From €5216EUR$5,250USD£4,337GBP
€7451EUR$7,500USD£6,195GBP
- Report
- August 2023
- 295 Pages
Global
From €6606EUR$6,650USD£5,493GBP
€9438EUR$9,500USD£7,847GBP
- Report
- August 2023
- 147 Pages
Global
From €3303EUR$3,325USD£2,747GBP
€4719EUR$4,750USD£3,924GBP
- Drug Pipelines
- July 2023
- 30 Pages
United States
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- February 2023
- 120 Pages
Global
From €5216EUR$5,250USD£4,337GBP
€7451EUR$7,500USD£6,195GBP
- Report
- February 2023
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- September 2022
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- August 2022
- 30 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- January 2022
- 130 Pages
Global
From €4833EUR$4,865USD£4,019GBP
€6904EUR$6,950USD£5,741GBP
- Report
- January 2022
- 90 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more